基本資料
種類: ETF
費用比率%: 0.60
資產淨值: 32.37
成立日期: 11/12/2017
 
分析
市值分佈:
90.48%
大市值
5.20%
中市值
1.27%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 19/09/2026 05:39) 總持有投資項目: 179  
0%
 
100%
     10大 (30.36%)
代號 名稱 佔比% ▼ 持有日期
BBIOBridgeBio Pharma0.2331/07/2026
IOVAIovance Biotherapeutics0.2231/08/2026
INCYIncyte Corp0.2231/08/2026
FIXComfort Systems USA0.2231/07/2026
TGTXTG Therapeutics0.2131/07/2026
ABBVABBVIE0.2131/08/2026
ORCLOracle Corp0.2131/08/2026
KLACKLA Corporation0.2131/07/2026
BIIBBiogen0.2131/08/2026
QUREuniQure NV0.2031/07/2026
DYNDyne Therapeutics0.2031/07/2026
REGRegency Centers Corp0.2031/08/2026
TXNTexas Instruments0.2031/08/2026
CRWDCrowdstrike Holdings Inc0.2031/08/2026
CYTKCytokinetics0.2031/08/2026
IMVTImmunovant0.1931/07/2026
TPLTexas Pacific Land Corporation0.1931/08/2026
SMMTSummit Therapeutics0.1931/08/2026
GRALGRAIL Inc.0.1931/07/2026
AMEAmetek0.1931/08/2026
  1    2   3    4    5    6    7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.